Navigation Links
PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
Date:2/1/2010

ANNAPOLIS, Md., Feb. 1 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has submitted a White Paper in response to the Broad Agency Announcement (Solicitation Number: BAA-BARDA-09-34) issued by the Biomedical Advanced Research and Development Authority (BARDA) for the Advanced Research and Development of Chemical, Biological, Radiological and Nuclear Medical Countermeasures.  In December 2009, this BAA was specially modified and extended to accommodate rPA-related submissions.  

David P. Wright, President and Chief Executive Officer of PharmAthene, commented, "In consultation with BARDA, today PharmAthene submitted a  White Paper for  advanced development of SparVax™ in response to the BAA.  If BARDA finds our submission acceptable, a formal proposal will be requested. We believe that, if awarded, funding provided under this BAA, along with potential additional funding under our existing contract with BARDA, will be sufficient to advance SparVax™ to a stage where it will be eligible for consideration for a Project BioShield procurement contract."

"There has been widespread acknowledgement across the scientific community of the need for a next-generation anthrax vaccine that offers the potential for improved safety, convenience and cost-effectiveness.  SparVax™ is the leading rPA-based vaccine and is well positioned to meet these requirements.   We look forward to continuing our work with the government to develop the necessary medical countermeasure to successfully deter or quickly respond to a biolog
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PharmAthene Appoints Jeffrey W. Runge, M.D. to the Companys Board of Directors
2. PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
3. PharmAthene Reports Third Quarter 2009 Financial and Operational Results
4. PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
5. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
6. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
7. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
8. PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
9. PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
10. PharmAthenes 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
11. PharmAthene Reports First Quarter 2009 Financial and Operational Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... NY (PRWEB) September 18, 2014 Whitehouse ... negotiations with Salem Realty Group and has acquired an ... space within the Salem Executive Complex adjacent to its ... was held on Friday September 5th. Whitehouse Labs is ... the entire space specifically for package testing. The prime ...
(Date:9/17/2014)... , Sept. 17, 2014 The global consumption of ... 2019. Squalene is a natural skin-identical chemical that finds applications ... care, food supplements, pharmaceuticals, and in other applications like high ... market has a few major players and is regionally segregated. ... Special Liver Oil Co. Ltd. ( Japan ), ...
(Date:9/17/2014)... PRINCETON, N.J. , Sept. 17, 2014 ... targeted therapeutic devices to address infectious disease, cancer and ... Inc. (ESI), disclosed today that each company will be ... On September 18 th , Sahil ... entitled: "Exosomes: A Multiplexed Platform for Clinical Management." ...
(Date:9/17/2014)... 17, 2014 A biodegradable polymer ... such as bacteria, fungi, and algae into smaller ... biomass, inorganic compounds, carbon dioxide, and humus in ... base and improved costs, biodegradable polymers are proving ... alternative to conventional polymers. Primary factors that are ...
Breaking Biology Technology:Whitehouse Labs Announces Package Testing Laboratory Expansion 2Whitehouse Labs Announces Package Testing Laboratory Expansion 3Whitehouse Labs Announces Package Testing Laboratory Expansion 4Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3Aethlon Medical and Exosome Sciences To Present at the Exosomes & SingleCell Analysis Summit 2Aethlon Medical and Exosome Sciences To Present at the Exosomes & SingleCell Analysis Summit 3Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 3
... Trial with James Pingpank, MD, FACS, as Principal Investigator , ... Delcath Systems, Inc. (Nasdaq: DCTH ) ... University of Pittsburgh Medical Center (UPMC), has joined ... (PHP) System against inoperable metastatic melanoma in the liver. ...
... CARMEL, Israel, December 2 InSightec Ltd. announced,today ... (MRgFUS) with the ExAblate(R) system has the potential ... that have spread to,the bones (bone metastases). The ... the,November 11 online issue of Annals of Surgical ...
... Calif., Dec. 2 Intradigm Corporation, a leading,developer ... the issuance of United States patent 7,459,547, entitled ... The issued,patent, which is based on the ... Cook Chair of Biomedical Sciences and Professor of ...
Cached Biology Technology:Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 2Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 3Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 4New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 3
(Date:9/17/2014)... have been growing significantly faster since the 1960s. The ... changed, but they have accelerated -- by as much ... study carried out by scientists from Technische Universitt Mnchen ... have been continuously observed since 1870. Their findings were ... decades ago, "forest dieback" was a hot topic, with ...
(Date:9/17/2014)... MSSA could be curbed by coating hospital surfaces ... of shark skin, according to research published in ... Infection Control . , The study modelled how ... disease bacteria through touching, sneezes or spillages. The ... formulated to resemble shark skin. The study showed ...
(Date:9/16/2014)... Ohio (September 17, 2014)The North American Menopause Society ... the comprehensive care of midlife womenon everything from ... "The North American Menopause Society Recommendations for Clinical ... in the Society,s journal Menopause . This ... for the care of midlife women freely available ...
Breaking Biology News(10 mins):Global change: Trees continue to grow at a faster rate 2Global change: Trees continue to grow at a faster rate 3Sharks' skin has teeth in the fight against hospital superbugs 2
... RICHLAND, Wash. -- Pollution is warming the atmosphere ... published May 10 in Geophysical Research Letters . ... the cooling that other clouds provide is not yet ... new-found warming into global climate models. Pollution ...
... but too much sugar can create a diabetic-like ... changes. Standard methods to monitor glucose levels require ... A team of engineers at the National University ... developing an alternative approach that takes advantage of ...
... gasoline, diesel, plastics, rubbers, and numerous chemicals that are ... this is not sustainable due to the limited nature ... associated with climate change and other environmental problems due ... to address above problems is the use of renewable ...
Cached Biology News:Pollution teams with thunderclouds to warm atmosphere 2Pollution teams with thunderclouds to warm atmosphere 3Production of chemicals without petroleum 2
...
Tissue-Stat ( Tissue Adherent for Mounting Formalin-Fixed and Frozen Tissue Sections.)...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
Clarin Mounting Medium (Permanent environmentally safe mounting medium for general histology & cytology use)...
Biology Products: